Berberine: Does The Supplement Called "Ozempic Natural" Really Work?

Berberine is a natural compound found in some plants that has sparked scientific interest due to its anti-inflammatory properties and its ability to influence the gut microbiota. Research indicates that it may help reduce inflammation in the gut and improve the balance of gut bacteria, which may be useful in the treatment of inflammatory bowel diseases. These effects are linked to communication between the gut, immune system, and brain. However, while promising, berberine still needs more studies to confirm its efficacy and safety in medical treatments.

In recent years, a supplement called berberine has gained enormous popularity on social media and health blogs. Many people have started calling it a "natural Ozempic," suggesting that it could help control weight, blood sugar, and even inflammation in the body.

However, scientists have been investigating more carefully what this substance actually does in the body. Recent studies show that its effects are complex and are mainly linked to gut health and communication between the gut and the brain.

The gut is often called the “second brain” because it constantly communicates with the nervous system. This communication occurs through three main pathways. The first is the neuronal pathway, in which nerve cells send signals directly between the gut and the brain.

The second is the hormonal pathway, in which chemicals produced by the body, such as stress hormones and mood-related neurotransmitters, circulate through the bloodstream and influence organ function. The third is the immune pathway, in which molecules produced by the body's defense system regulate inflammation and immune responses.

Together, these three systems form a network known as the gut-brain axis, which allows for constant communication between digestion, emotions, and overall health.

The gut also harbors a vast community of microorganisms, primarily composed of bacteria. This group is called the gut microbiota. These bacteria help digest food, produce important molecules, and protect the body against harmful microorganisms.

When this balance is disrupted, a phenomenon called dysbiosis, inflammation and intestinal diseases can arise. Among these diseases are Crohn's disease and ulcerative colitis, which are part of a group called inflammatory bowel disease. In these conditions, the immune system overreacts and causes prolonged inflammation in the intestine, leading to abdominal pain, diarrhea, and other digestive problems.

Current treatments for these diseases often use medications that reduce inflammation or decrease the activity of the immune system. Some of these medications are effective, but can cause significant side effects, such as liver problems, blood disorders, or an increased risk of infections. Because of this, scientists have been searching for new therapeutic alternatives, including natural compounds that can help control inflammation without causing so many adverse effects.

It is in this context that berberine emerges, a natural substance found in various plants traditionally used in herbal medicine. Berberine belongs to a group of plant compounds called alkaloids, which are molecules produced by plants with different biological functions.

Research shows that berberine has anti-inflammatory, antibacterial, and antifungal properties, meaning it can help reduce inflammation and fight certain microorganisms. Furthermore, some studies indicate that it may positively influence the functioning of the nervous system and even slow down processes related to neurodegenerative diseases.

One of the most interesting findings is that berberine appears to act primarily on the gut ecosystem. It can alter the balance of intestinal bacteria, favoring some species considered beneficial and reducing others associated with inflammation.

To investigate these effects, scientists analyze gut samples and use genetic sequencing techniques, which allow them to identify which bacteria are present and in what quantities. Other studies use molecular analyses to observe how berberine influences the production of inflammatory substances in the body.

Interestingly, the gut itself helps activate berberine. Bacteria present in the microbiota can transform this substance into even more active molecules. This is important because berberine is not easily absorbed by the body when ingested. Even so, these chemical transformations within the gut can enhance its local effects, helping to reduce inflammation and improve the balance of the microbiota.

Despite these promising results, scientists warn that it is still too early to consider berberine a miracle cure for metabolic or intestinal problems. Many studies are still underway, and the effects observed in the laboratory do not always replicate in the same way in humans.

Therefore, although berberine is an interesting and potentially useful compound for future therapies, its use as a substitute for medication or as a "miracle cure" still needs much more scientific evidence.

READ MORE:

Berberine in Bowel Health: Anti-Inflammatory and Gut Microbiota Modulatory Effects

Anna Duda-Madej, Szymon Viscardi, Jakub Piotr Łabaz, Ewa Topola, Wiktoria Szewczyk, and Przemysław Gagat

International Journal of Molecular Sciences. 2025, 26(24), 12021;DOI: 10.3390/ijms262412021

Abstract:

Disruption of the gut-microbiome-brain axis contributes to the development of chronic inflammation, impaired intestinal barrier integrity, and progressive tissue damage, ultimately reducing quality of life and increasing risk of comorbidities, including neurodegenerative diseases. Current therapies are often limited by adverse effects and insufficient long-term efficacy, highlighting the need for more comprehensive therapeutic approaches. Berberine (BRB), a plant-derived isoquinoline alkaloid, has attracted growing attention due to its pleiotropic immunomodulatory, neuroprotective, and gut-homeostasis-modulating properties, which involve reshaping the gut microbiota and underscore its therapeutic relevance within the gut-microbiome-brain axis. The aim of this review is to synthesize current scientific evidence regarding the anti-inflammatory mechanisms of BRB in inflammatory bowel disease (IBD). We compare its activity with first-line therapies and discuss its impact on microbial composition, including the bidirectional regulation of specific bacterial taxa relevant to intestinal and systemic disorders that originate in the gut. Furthermore, we emphasize that gut bacteria convert BRB into bioactive metabolites, contributing to its enhanced intraluminal activity despite its low systemic bioavailability. By integrating molecular and microbiological evidence, this review fills a critical knowledge gap regarding the comprehensive therapeutic potential of BRB as a promising candidate for future IBD interventions. The novelty of this work lies in unifying fragmented findings into a framework that explains how BRB acts simultaneously at the levels of host immunity, microbial ecology, and neuroimmune communication, thus offering a new conceptual model for its role within the gut-microbiome-brain axis.